News and Press Releases
Verisense Health Elects Josh Tolkoff to its Board of Directors
Josh brings extensive medical device, investment and growth management experience to his new role 9 May 2024 -- Massachusetts, US -- Verisense Health, a digital health technology and data company,...
Category: Biotechnology, Other
Posted: May 9, 2024
Gilead Sciences Appoints Peter Wickersham to Vice-President and General Manager in the UK and Ireland
7 May 2024 -- London, UK -- Gilead Sciences announced today the appointment of Peter Wickersham as vice-president and general manager for the UK and Ireland. In his new role,...
Category: Drug Discovery, Pharmaceutical
Posted: May 7, 2024
Barinthus Bio Names Experienced Physician, Leon Hooftman MD, as Chief Medical Officer
Dr Hooftman brings more than 25 years’ experience in international drug development including immunology, autoimmunity, haematology, oncology and infectious diseases 1 May 2024 -- Oxford, UK -- Barinthus Biotherapeutics, formerly Vaccitech, a clinical-stage biopharmaceutical...
Category: BioManufacturing, Drug Discovery
Posted: May 1, 2024
ProBioGen Announces Change in Management
30 April 2024 -- Berlin, Germany -- ProBioGen AG, a premier contract development and manufacturing organisation (CDMO) and technology provider with extensive expertise in cell line engineering, process development and GMP...
Category: BioManufacturing, Other
Posted: April 30, 2024
Sphere Fluidics appoints Dale Levitzke as Chief Executive Officer
Dale Levitzke joins as Dr Frank F Craig, current CEO and co-founder, announces his retirement after leading the company for 14 years 30 April 2024 -- Cambridge, UK -- Sphere...
Category: Biotechnology, Other
Posted: April 30, 2024
The Jonas Webb Building, Babraham Research Campus, Babraham, Cambridge CB22 3AT, United Kingdom
Calluna Pharma appoints Margrethe Sørgaard as Senior Vice President of Clinical Operations and Pharmacovigilance
First senior executive appointment made following Company launch to oversee strategic development of clinical programmes 23 April 2024 -- Oslo, Norway -- Calluna Pharma, a clinical stage company pioneering a...
Category: Other, Pharmaceutical
Posted: April 23, 2024
G.ST Antivirals reports start of Phase 2 trial and announces appointment of Ronald Bruce Turner as new Chief Medical Officer
Phase 2 clinical trial started, first subject in on 2 April 2024 New CMO Ronald Bruce Turner MD, distinguished expert in the clinical research of rhinoviruses, to oversee trial and...
Category: Biotechnology, Clinical Trials
Posted: April 9, 2024
Experimental gene therapy for giant axonal neuropathy shows promise in NIH clinical trial
Treatment for rare childhood disease was well tolerated and slowed loss of motor function 20 March 2024 -- Maryland, US -- An investigational gene therapy for a rare neurodegenerative disease...
Category: Clinical Trials, Drug Discovery
Posted: March 20, 2024
Kindeva Drug Delivery Welcomes Jennifer Riter, New Vice President of Analytical Services
18 March 2024 -- Minnesota, US, and Missouri, US -- Kindeva Drug Delivery, a global leader in drug-device combination products, today welcomes Jennifer Riter as vice president of Analytical Services to...
Category: Drug Delivery
Posted: March 18, 2024
Faller Packaging announces long-term appointment of new chief executive officer
Dr Michael Faller and Dr Daniel Keesman will step down for reasons of age in the second half of 2024. Dagmar Schmidt will become the new CEO 13 March 2024...
Category: Manufacturing and Packing
Posted: March 13, 2024
Veramed appoints Karen Curran as Chief Strategy Officer
12 March 2024 -- LONDON, UK -- Specialist Biometrics CRO, Veramed, today announced the appointment of Karen Curran as chief strategy officer at Veramed. Karen joins during a period of...
Category: Other
Posted: March 12, 2024
Clinigen boosts senior team with three strategic hires
12 March 2024 -- London, UK -- Clinigen, the global pharmaceutical services company, today announces three strategic appointments to advance its transformation into a world leading pharma services company: Nihad...
Category: Other
Posted: March 12, 2024
New Data Demonstrate Sunbird Bio’s APEX Diagnostic Test Accurately Differentiates Key Alzheimer’s Disease Biomarker in Blood
Blood-based diagnostic effectively discriminated between patients who were positive versus negative for amyloid beta on PET scans Data will be shared in a poster presentation at AD/PD 2024 on 8-9...
Category: Biotechnology
Posted: March 5, 2024
PharmaKure announces epigenetics collaboration with Sheffield Hallam University to understand mechanisms of Alzheimer’s Diseases
New collaboration will enhance ability to identify those more at risk of developing brain diseases to enable earlier interventions 29 February 2024 -- Manchester, UK -- PharmaKure, a clinical stage...
Category: Other
Posted: February 29, 2024
Alderley Park Congleton Road Nether Alderley Open Access Lab 19S6 Macclesfield SK10 4TG
Galimedix Therapeutics announces new pre-clinical data with GAL-201 in an Alzheimer’s disease transgenic model to be presented at AD/PD 2024 Conference
Galimedix’s novel, orally administered small molecule offers the hope of changing the course of disease by targeting amyloid beta oligomers and protofibrils 28 February 2024 -- Maryland, US -- Galimedix...
Category: Biotechnology
Posted: February 28, 2024
